鼻腔滴注聚维酮碘改善已致敏的Der p1诱导变应性鼻炎小鼠模型的持续性黏膜炎症
该研究在体外用屋尘螨或Der p1与全长重组人IL-33孵育,并行免疫印迹检测;体内将50只BALB/c小鼠分为对照组、磷酸盐缓冲液处理的变应性鼻炎组、聚维酮碘处理组、E64处理组和地塞米松处理组。结果显示聚维酮碘处理减轻鼻部症状、抑制变应性炎症、降低鼻灌洗液中IL-33、IL-5、IL-13水平及血清总IgE和特异性IgE,并减少鼻黏膜嗜酸性粒细胞和杯状细胞。
要点
- 聚维酮碘处理可减轻变应性鼻炎小鼠的鼻部摩擦和打喷嚏症状。
- 聚维酮碘降低鼻灌洗液IL-33、IL-5、IL-13及血清总IgE和特异性IgE水平。
- 组织学显示聚维酮碘组鼻黏膜嗜酸性粒细胞和杯状细胞较变应性鼻炎组减少。
核心结论
- 研究提示鼻腔冲洗聚维酮碘可能通过抑制IL-33活化、抑制变应性炎症成为变应性鼻炎有前景的治疗选择。
研究设计与样本
- 体外实验使用全长重组人IL-33与屋尘螨或屋尘螨1(Der p1)等变应原,采用免疫印迹法检测。
- 体内实验将50只BALB/c小鼠分为五组:对照组(CON)、磷酸盐缓冲液处理的变应性鼻炎组(AR)、聚维酮碘处理组(AR+PVP)、E64处理组(AR+E64)和地塞米松处理组(AR+Dexa)。
- 检测指标包括鼻部症状评分(摩擦和打喷嚏)、鼻灌洗液细胞因子水平、血清免疫球蛋白浓度、鼻黏膜逆转录聚合酶链反应及组织学分析。
主要发现
- 聚维酮碘处理减轻鼻部症状、抑制变应性炎症,并降低鼻灌洗液中IL-33、IL-5、IL-13水平及血清总IgE和特异性IgE水平。
- 组织病理学分析显示,与AR组相比,AR+PVP组鼻黏膜中嗜酸性粒细胞和杯状细胞数量减少。
- 逆转录聚合酶链反应和免疫荧光染色证实,与变应性炎症相关的基因和蛋白表达下调。
临床怎么用
- 原文结论为鼻腔冲洗聚维酮碘可能成为管理变应性鼻炎的有前景治疗选择,此为该研究的提示性结论。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Interleukin (IL)-33, when cleaved into smaller fragments by proteases, becomes hyperactive, contributing to allergic inflammation. Povidone-iodine (PVP-I) is an iodine-based compound that exhibits antimicrobial properties and inhibits proteases. This study aimed to investigate whether PVP-I treatment inhibits IL-33 cleavage, improves allergic rhinitis (AR) symptoms, and suppresses allergic inflammation in a mouse model. METHODS: In vitro experiments using full-length recombinant human IL-33 and allergens, including house dust mites or Dermatophagoides pteronyssinus 1, were conducted using western blotting. Fifty BALB/c mice were divided into five groups: control (CON), AR with phosphate-buffered saline treatment (AR), PVP-I treatment (AR + PVP), trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (E64) treatment (AR + E64), and dexamethasone treatment (AR + Dexa). Nasal symptom scores, including rubbing and sneezing, were measured. The cytokine levels in the nasal lavage fluid (NLF) and the concentration of immunoglobulins in the blood serum were assessed. Nasal mucosa from each group was used for reverse transcriptase-polymerase chain reaction (RT-PCR) and histological analyses were conducted. RESULTS: PVP-I treatment reduced nasal symptoms, suppressed allergic inflammation, and decreased the levels of IL-33, IL-5, and IL-13 in the NLF and total immunoglobulin E (IgE) and specific IgE in the serum. Histopathological analysis revealed a reduction in the number of eosinophils and goblet cells in the nasal mucosa of the AR + PVP group when compared to the AR group. RT-PCR and immunofluorescence staining confirmed the downregulation of genes and proteins associated with allergic inflammation. CONCLUSIONS: These findings suggest that nasal irrigation with PVP-I may be a promising therapeutic option for managing AR by inhibiting IL-33 activation and suppressing allergic inflammation.
引用
- Kang JY, Choi MR, Kim YM, et al. Nasal instillation of povidone-iodine ameliorates ongoing mucosal inflammation in a pre-sensitized murine model of Der p1-induced allergic rhinitis. Int Forum Allergy Rhinol. 2023. PMID: 38078671. doi:10.1002/alr.23308
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。